C
Corporate
P
Profile fil August ugust 2013
0 3
Agenda
Dabur India-Introduction
FMCG Industry Scenario
Business Overview
Strategy Overview
Recent Performance
2
Introduction
Established in 1884 ‐ more than 128
Years of Trust & Excellence
World’s largest in Ayurveda and natural healthcare
Sales of Rs. 61.5 billion and profits of l f b ll d f f Rs. 7.6 billion in FY2012‐13
Dabur ranked amongst the
Top 5 Indian companies with the best Board of Directors
Dabur India Ltd Bags Golden
Peacock Award For Excellence p In Corporate Governance 2012
In FMCG Sector
20 world class manufacturing facilities
20
ld l f t i f iliti catering to needs of diverse markets
Strong overseas presence with 31%
Strong overseas presence with 31% contribution to consolidated sales
14
billion Rupee brands
Dabur bags People's Choice
Corporate Green Star Award for 2012 for its environment‐ focussed initiatives
58
5.8
Dabur ranked amongst India's
Most Admired Companies by
Forbes India
mn retail outlet reach in India
3
Vision and Core Values
Vision
• Dedicated to the health and well being of every household
Ownership
Passion
for
Winning
Integrity
Core
Values
People
Developm
ent
Innovation
Team
Workk
Consumer
Focus
4
Key Milestones
1884
1972
1986
•Dr. SK Burman started an Ayurvedic Pharmacy in Kolkatta
•The company shifted base to Delhi from
Kolkata
•Registered as Public
Limited Company
1994
1998
2003
•Listed
Li t d on the th Bombay
B
b
Stock Exchange
•Professionalized
P f i li d with ith Burman Family handing over day to management •Pharmaceutical
Ph
ti l B
Business
i de-merged to focus on core FMCG business
2004
2005
2006
International Business
•International
set up in Dubai to tap overseas opportunity
Acquired Balsara
•Acquired
strengthening Oral care
& gaining entry into
Home care
Dabur Figured in Top 10
•Dabur
Great Places To Work
2008
2010
2013
•Acquired Fem Care
Ph
Pharma entering t i mainstream Skin care
• Overseas acquisitions -
•Crossed Rs. 60 bn mark in annual sales and
Market Cap of US$5 billion Hobi Group,
Group Turkey and
Namaste Labs, US
5
Performance Overview
Sales
in INR bn
28.1
33.9
FY09
FY10
52.8
40.8
FY11
FY12
61.5
“Robust profitable growth translating into superior shareholder returns”
FY13
Market Capitalization
Market Capitalization in INR bn
EBITDA
238.9
in INR bn
16.0
14.0
12.0
10.0
8.0
6.0
5.2
6.7
8.3
9.5
FY11
FY12
11 2
11.2
137 8
137.8
167.2
185.4
85.4
4.0
2.0
0.0
FY09
FY10
FY09
FY10
FY11
FY12
FY13
Profit after Tax
11 0
11.0
in INR bn
9.0
7.0
5.0
FY13
3.9
5.0
5.7
6.4
FY10
FY11
FY12
7.6
30
3.0
1.0
‐1.0
FY09
FY13
6
Business Footprint
UK
Turkey
U.S.
Egypt
UAE
Nepal
B’Desh
Nigeria
Sri Lanka
Domestic Mfg.
Locations
Key markets
Manufacturing Facilities
Our strategy is to localize manufacturing, supply chain and product offerings to suit consumer requirements in each geography
7
Our Billion Rupee Brands
Home &
Personal Care
Health Care
Foods
8
Research & Development Focus
Team of scientists including
Ayurvedic doctors, Pharmacists,
Agronomists, Botanists, Tissue
Culture specialists, etc.
Strong New Product Development
Ayurvedic Medicines
Personal Care
Foods
Home Care
A
Agro
Bi
Biotech
t h Initiatives
I iti ti
OTC Healthcare
Protecting endangered herbs
Technical assistance to farmers
Contract cultivation of herbs
Green House at Nepal
Dabur Research Facilities
“Nearly 25 new products and variants introduced in FY 2013” d d
”
Agronomy Initiatives : Greenhouse at Dabur
Nepal & Uttaranchal
Nepal & Uttaranchal
9
Dabur - Domestic Distribution Structure
Factory
Depot
Stockists
Super stockists
((Carry & Forward Agents) y g
)
Insti Stockists
Modern Trade
Stockist
Wholesalers
Sub stockists
Sub stockists
Retail trade
Rural trade
Shoppers & Consumers
Insti customers
Direct reach 0.8 mn outlets
“Total reach at 5.8 mn retail outlets, one of the